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Practically convenient methods have been developed for the
preparation of new iridium complexes, possessing bulky
N-heterocyclic carbene and phosphine ligands; these routinely
handled complexes are highly active catalysts within directed
hydrogen isotope exchange processes.
In attempts to combat high failure rates in modern drug
development, the global pharmaceuticals industry has been
placing increasingly greater emphasis on earlier stage meta-
bolic studies. One of the most eﬀective ways to follow drug
metabolism is to use site-speciﬁc labelling, most conveniently
with a heavy isotope of hydrogen. Within the ﬁeld of hydrogen
isotope exchange (HIE), the ideal situation would be to utilise
sub-stoichiometric quantities of a transition metal catalyst to
carry out the required transformation on a fully functionalised
compound (e.g. Scheme 1), thereby avoiding any additional,
time-consuming and costly, synthetic endeavours. In attempts
to meet the demand for such a process, a range of platinum-,1
rhodium-,2 and iridium-based3 complexes have been applied
to the area, each of which has shown varying degrees of
eﬃcacy. Perhaps the most eﬀective complex used in this ﬁeld
is Crabtree’s catalyst.4 However, whilst showing activity
across a range of substrates, this complex is regularly required
in (super-)stoichiometric amounts, and often leads to low
isotope incorporation levels and undesirably lengthy reaction
times.5 Further, in our experience, usage of Crabtree’s catalyst
in tritium exchange reactions leads to high amounts of
(tritiated) waste which has environmental implications. Hence,
there is a distinct requirement for a robust and catalytically
viable set of metal-complex systems for use in such exchange
processes and which will label to a high degree over a range of
substrates. Herein, we report our initial endeavours to develop
a series of new iridium complexes which would deliver these
objectives.
Nolan6 and Buriak7 have elegantly established that manip-
ulation of the ligand sphere around iridium can improve both
stability and catalytic activity relative to Crabtree’s catalyst,
albeit within the ﬁeld of alkene hydrogenation. Consequently,
our initial eﬀorts focused upon the preparation of iridium
complexes with greater steric demand around the metal centre.
In this regard, it was felt that the speciﬁc combination of a
bulky N-heterocyclic carbene (NHC),8 such as 1,3-bis(2,4,6-
trimethylphenyl)imidazol-2-ylidene (IMes), with an appreci-
ably encumbered phosphine, would serve to deliver robust and
eﬀective complexes for use within exchange studies.
In terms of access to the desired complexes, despite describ-
ing routes to related species, Buriak was less successful in
attempts to prepare compounds possessing both a relatively
bulky phosphine and a more sterically-demanding NHC.7 In
contrast, as part of this programme, a modiﬁcation of Herr-
mann’s procedure, for in situ generation and introduction of
the NHC ligand,9 was employed to deliver a range of novel
iridium complexes (Table 1). In the developed protocol, use of
a relatively non-coordinating solvent such as benzene in the
initial steps was found to be essential; more polar solvents (e.g.
ethanol, THF, or diethyl ether) led to either diﬃcult isolation
or ineﬃcient preparative processes. Isolation and handling of
Scheme 1 Ideal hydrogen isotope exchange process.
Table 1 Preparation of iridium complexes 5a–ea
Entry Heterocycle PR3 Complex Yield (%)
b
1 4a PPh3 5a 62
2 4a PBn3 5b 59
3 4a PMe2Ph 5c 71
4 4b PnBu3 5d 30
5 4b PPh3 5e 31
a Reaction conditions: (a) NaOEt, PhH, r.t., 10 min; (b) 4a or 4b,
PhH, r.t., 5 h; (c) AgPF6, THF, r.t., 30 min; (d) PR3, THF,
r.t., 2 h. b Isolated yields.
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the carbene ligand is also avoided by the established synthetic
strategy, with no glove box techniques being required. By
employing this preparative method, a number of previously
unreported iridium complexes were readily prepared in mod-
erate to good yields. These complexes are all highly coloured
and are air- and moisture-stable solids, which were fully
characterised by NMR, mass spectral, and crystallographic
techniques.z The crystal structure of complex 5c is illustrated
in Fig. 1.10,11
With the new Ir compounds in hand, their ability to catalyse
the requisite HIE reactions was examined by using standard
conditions of 5 mol% of the Ir complex in DCM under 1
atmosphere of deuterium gas. Initially, we chose to apply
substrates (6a–g) which label through a ﬁve-membered
metallocyclic intermediate (5 mmi). At only 5 mol% Ir load-
ing, high levels of deuterium incorporation were readily
realised (7a–g; Table 2). Importantly, the position of incor-
poration was entirely predictable, completely regioselective,
and reproducible. The further ﬂexibility of the new complex
systems was illustrated by the application of more demanding
substrates, which label through a six-membered metallocyclic
intermediate (6 mmi). As can be seen from the ﬁnal two
compounds in Table 2, the simplest substrate, acetanilide, is
readily labelled by the catalysts examined, and the benzanilide
functionality sees eﬃcient incorporation via both 5 and 6
mmi’s. From these results, catalysts 5a–c are clearly capable
of eﬃciently labelling ketones, amides, heterocycles, and
nitroarenes to equally high levels. Traditionally more diﬃcult
substrates such as benzamide3c,d,5 and N-phenylpyrazole5 are
also readily tolerated, as is a tertiary benzamide, notably
without incorporation into the N-ethyl units. In contrast,
eﬃcient labelling of such substrates with Crabtree’s catalyst
typically requires considerably higher complex loadings up to
110 mol%.5 Furthermore, the success in labelling nitroarenes
is particularly noteworthy, since such substrates have proved
to be especially challenging, with previously employed cata-
lysts leading to only low levels of incorporation and even
reduction of the nitro unit.3b,e,5
In terms of the saturated NHC-containing complexes, for
example, 5e showed good levels of labelling with some sub-
strates (e.g. 99% for acetophenone and 92% for N-phenylpyr-
azole, both at 5 mol% loading) but was not quite as
generally eﬀective across the full spectrum of compound types
applied.
To further explore the capabilities of these catalysts, a
loading study showed that excellent D incorporation is achiev-
able, even with catalyst levels as low as 0.5 mol% (Scheme 2).
In terms of reaction time, at a loading of only 0.5 mol%,
complex 5c is capable of almost complete incorporation of
deuterium after only 90 minutes; 5a and 5b behaved just as
eﬀectively at the same 0.5 mol% loading to ﬁrmly establish the
extremely high level of catalytic activity displayed by this series
of new Ir complexes.
Presently, we believe that the combination of two encum-
bered ligand systems is key to the observed catalytic activity of
the complexes prepared as part of this programme. This may
be related to two factors. Firstly, the bulky carbene and
phosphine could impart greater stability upon the catalytic
intermediates involved in the reaction, preventing the
formation of inactive iridium clusters3 (or promoting the
existence of active Ir-based monomeric species7b). Alterna-
tively, the electron-rich and sterically crowded ligand sphere
may aid both the oxidative addition and reductive elimination
steps within the overall exchange mechanism. To conﬁrm
the requirement for sterically demanding ligand systems, we
prepared two complexes which were reported by Buriak:7
Fig. 1 Molecular structure of the cationic portion of 5c with dis-
placement ellipsoids set at 50% probability. Selected bond lengths (A˚);
Ir(1)–C(1) 2.079(3), Ir(1)–P(1) 2.3239(8), Ir(1)–C(22) 2.222(3),
Ir(1)–C(23) 2.170(3), Ir(1)–C(26) 2.221(3), Ir(1)–C(27) 2.167(3).
Table 2 HIE studies with complexes 5a–ca,b
a 5 mol% of Ir catalyst employed over 16 h. b Average incorporation
into the positions shown over two separate reaction runs; the percen-
tage given refers to the level of D incorporation over the total number
of positions shown, e.g. 97% for the two possible positions in 7a
indicates 1.94D incorporation.
Scheme 2 Catalyst loading and labelling time study.
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(COD)IrPnBu3(IMe) 8a, and (COD)IrPnBu3(IMes) 8b. When
applied within attempted labelling processes with acetophe-
none, complex 8a, bearing the considerably less bulky IMe
ligand, was completely inactive. In contrast, complex 8b is a
competent exchange catalyst over a range of substrates.
Having stated this, complex 8b was not as generally eﬀective
(e.g. only a 56% D incorporation with 2-phenylpyridine at 5
mol% loading) as the iridium species, 5a–c. Further studies
into general ligand eﬀects in this area are ongoing and will be
reported in due course.
Finally, since benzanilides are capable of labelling through
both a 5 and a 6 mmi (see 7i, Table 2), we wondered whether
the new catalyst systems could be employed to deliver selective
exchange within such substrates; this would be of considerable
practical use, particularly for application in pharmaceutically-
based metabolism studies. As shown in Scheme 3, complex 5c
shows very high isotope incorporation via both possible
metallocyclic intermediates at 5 mol% loading. Pleasingly,
reduction in catalyst 5c loading has a dramatic eﬀect upon
the level of D incorporation into the position (b) activated
through a 6 mmi, while the position (a), labelled via a 5 mmi,
sees consistently high D uptake. This study illustrates a further
distinct practical advantage delivered by these novel iridium
catalyst systems. To our knowledge, this level of labelling
selectivity is unprecedented in the literature.
In summary, practically accessible methods for the prepara-
tion of a range of novel, robust, and readily handleable
iridium(I) complexes, bearing a bulky NHC–phosphine ligand
combination, have been established. These complexes have
revealed catalytic activity in exchange processes far in excess of
the industry standard, Crabtree’s catalyst, with excellent levels
of labelling being achievable over short reaction times and at
extremely low metal complex loadings. The ability to perform
selective labelling via a 5 mmi, over a 6 mmi, has also been
shown to be possible. One further practical beneﬁt relates to
the prolonged stability of these complex species; for example,
following storage under an air atmosphere at room tempera-
ture for over 8 months, complex 5c (5 mol% loading) was
shown to be signiﬁcantly active in delivering 95% D incor-
poration within substrate 6d after 16 h at room temperature.
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